SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit
11 references·1 citing·39 second hop
Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit (2003)Potential savings from increased use of g…Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors (2002)Outcomes of Reference Pricing…Self-restriction of medications due to cost in seniors without prescription coverage (2001)Self-restriction of medicatio…Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)Adverse Events Associated Wit…Drug Coverage And Drug Purchases By Medicare Beneficiaries With Hypertension (2000)Drug Coverage And Drug Purcha…Users' Guides to the Medical Literature (1999)Users' Guides to the Medical …The Importance of the Physician in the Generic versus Trade-Name Prescription Decision (1998)The Importance of the Physici…A Physician Survey on Generic Drugs and Substitution of Critical Dose Medications (1997)A Physician Survey on Generic…Generic Drugs (1996)Generic DrugsBioequivalence and Narrow Therapeutic Index Drugs (1995)Bioequivalence and Narrow The…A Critical Analysis of Studies of State Drug Reimbursement Policies: Research in Need of Discipline (1993)A Critical Analysis of Studie…Generic Drugs and the Prescribing Physician (1987)Generic Drugs and the Prescri…Determinants of generic drug substitution in Switzerland (2011)Determinants of generic drug …Payment Restrictions for Prescription Drugs under Medicaid (1987)Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes (1991)Cost-Lowering Strategies Used by Medicare Beneficiaries Who Exceed Drug Benefit Caps and Have a Gap in Drug Coverage (2004)Effects of Prescription Drug User Fees on Drug and Health Services Use and on Health Status in Vulnerable Populations: A Systematic Review of the Evidence (2004)Out-of-Pocket Health-Care Expenditures among Older Americans with Cancer (2004)Estimating Nonresponse Bias in Mail Surveys (1977)Economic Consequences of Underuse of Generic Drugs: Evidence from Medicaid and Implications for Prescription Drug Benefit Plans (2003)Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians (2015)Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries. (1999)Prescription Drug Coverage, Utilization, And Spending Among Medicare Beneficiaries (1999)Self-restriction of Medications Due to Cost in Seniors without Prescription Coverage: A National Survey (2001)The effects of cost-sharing on essential drug prescriptions, utilization of medical care and outcomes after acute myocardial infarction in elderly patients. (2002)Effect of the Medicare Part D Coverage Gap on Medication Use Among Patients With Hypertension and Hyperlipidemia (2012)METHODS FOR ANALYZING HEALTH CARE UTILIZATION AND COSTS (1999)Proposal of the Physicians' Working Group for Single-Payer National Health Insurance (2003)Benefits And Risks Of Increasing Restrictions On Access To Costly Drugs In Medicaid (2004)The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use (2013)On the Pooling of Time Series and Cross Section Data (1978)Designing Economic Agents that Act Like Human Agents: A Behavioral Approach to Bounded Rationality (1991)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry (2000)Competition, Innovation and Productivity Growth: A Review of Theory and Evidence (2002)Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997–2000 (2005)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials (1997)Users' Guides to the Medical Literature (1999)Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses (2003)Assessing Evidence Inconsistency in Mixed Treatment Comparisons (2006)Evaluation of networks of randomized trials (2007)Free for All? Lessons from the RAND Health Insurance Experiment (1995)Pharmacy Benefits and the Use of Drugs by the Chronically Ill (2004)Prescription drug cost sharing: associations with medication and medical utilization and spending and health. (2007)Medical Bankruptcy in the United States, 2007: Results of a National Study (2009)Drug substitution in transplantation: A National Kidney Foundation white paper (1999)What’s in a Name? Use of Brand versus Generic Drug Names in United States Outpatient Practice (2007)Management of Narrow Therapeutic Index Drugs (1999)Inadequate Prescription-Drug Coverage for Medicare Enrollees — A Call to Action (1999)Transforming Insurance Coverage Into Quality Health Care (2000)Effective healthcare cost-containment policies: A systematic review (2018)
this work references cited by second hop

References

  • 2001Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons873 cited
  • 1998The Importance of the Physician in the Generic versus Trade-Name Prescription Decision300 cited
  • 2001Self-restriction of medications due to cost in seniors without prescription coverage246 cited
  • 2002Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors178 cited
  • 1999Users' Guides to the Medical Literature177 cited
  • 1993A Critical Analysis of Studies of State Drug Reimbursement Policies: Research in Need of Discipline169 cited
  • 1997A Physician Survey on Generic Drugs and Substitution of Critical Dose Medications104 cited
  • 1995Bioequivalence and Narrow Therapeutic Index Drugs93 cited
  • 1987Generic Drugs and the Prescribing Physician81 cited
  • 2000Drug Coverage And Drug Purchases By Medicare Beneficiaries With Hypertension76 cited
  • 1996Generic Drugs68 cited

Cited by

  • 2011Determinants of generic drug substitution in Switzerland53 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work